Analyst Ratings for Neurogene (NGNE)
NGNE Rating Summary
NGNE Price Target Summary
- Highest: $70.00 (H.C. Wainwright)
- Lowest: $46.00 (Stifel)
- Average: $54.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$54.00 (+143.6%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
Avg. $ Target:
$54.00 (+143.6%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/26/2026 | LifeSci Capital | Patrick Dolezal | New Coverage | Outperform (N/A) |
50.00 (N/A) |
18.31 (22.17) |
21.08% | Details |
| 6/17/2025 | Craig-Hallum | Albert Lowe | New Coverage | Buy (N/A) |
50.00 (N/A) |
18.97 (22.17) |
16.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
